Global News and Digital Insights
for the Healthcare Industry

Bayer AG aims to invest $1B in drug research and development in the United States

Bayer AG (BAYGn.DE) aims to invest $1 billion in medicinal research and development in the United States this year as part of its efforts to treble its sales in the country by the end of the decade. Sebastian Guth, head of Bayer’s medicines division in the Americas, also stated that the firm has increased the number of marketing workers in the United States by around 50% in the previous three years and aims to increase that figure by another 75% by 2030. Bayer is aiming to expand its portfolio of new pharmaceuticals in order to boost share prices. Guth anticipates that cancer treatment Nubeqa, kidney medication Kerendia, and two of its top pipeline assets, experimental stroke drug Asundexian and experimental women’s health drug Elinzanetant, will generate peak revenues of 12 billion euros.

Read more from Reuters
Facebook
Twitter
LinkedIn

HealthGeniuses

According to Business Wire, global Healthcare Industry will be worth $12T by 2022. Healthcare is vast and highly fragmented with a mix of public and private players. It comprises healthcare providers such as hospitals, pharmaceuticals, and related life sciences. Digitisation and Post-Covid world are set to transform the healthcare industry in the coming decade. Top 5 trends include: Personalisation of patient care, new healthcare delivery models, convergence of food and health, increased global collaboration, and cloud-based electronic health records. HealthGeniuses.com is a business newsletter that curates latest innovations and disruptions in the Top 5 healthcare industry trends above from 100+ journals globally. Sign up to our weekly newsletter
All Posts

HealthGeniuses

Curated News and Digital
Insights for the Healthcare Industry

IndustryGeniuses
GroceryGeniuses
ConsumerGeniuses
MetaGeniuses
FashionGeniuses

HealthGeniuses

According to Business Wire, global Healthcare Industry will be worth $12T by 2022. Healthcare is vast and highly fragmented with a mix of public and private players. It comprises patients and healthcare providers such as hospitals, pharmaceuticals, and related life sciences.

Digitisation and Post-Covid world are set to transform the healthcare industry in the coming decade. Our weekly business newsletter covers innovations and disruptions in the Healthcare industry with global coverage.

HealthGeniuses is managed by IndustryGeniuses (A place where industries meet innovation). We are rolling out content platforms for the world’s hottest industries such as Food & Grocery Retail, Consumer Goods and Healthcare. For each of these key industries, we support Tech Startups and Industry Disruptors as they roll out next generation digital initiatives.

IndustryGeniuses team brings practical domain knowledge of working with 300+ tech startups and brands over the past decade.

© 2024 IndustryGeniuses Ltd. All Rights Reserved.